Novo CEO pressed by Senate to cut price ranges of being overweight, diabetic issues medication CEO Lars Fruergaard Jørgensen explained to lawmakers the company would look at new talks with insurers regarding the record charges of Wegovy and copyright should they pledge to keep the medicines on their formularies. This https://edgaruslbr.blogtov.com/11141299/the-smart-trick-of-healthcare-news-that-no-one-is-discussing